01276.HK
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 50.70
+0.10%Margins
Gross margin
85.9%
EBITDA margin
29.2%
EBIT margin
27.8%
Net margin
27.1%
FCF margin
18.9%
12.9%
Return on equity
11.3%
Return on assets
13.2%
Return on invested capital
0.44x
Asset turnover
HKD 11.6B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026